Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/26 17:29 | 7/28/26 | NBIX | Health | BioPrd | Biological Products, (No Diag | Norwalk Leslie V | CA | D | 2 | S.d | -438 | 175.03 | 0 | -3 | 3 | D | ||||||||||||||||
7/13/26 16:27 | 7/10/26 | NBIX | Health | BioPrd | Biological Products, (No Diag | Delaet Ingrid | CA | O | Chief Re | 3 | S.dm | -3,748 | 176.80 | 0 | -21 | 16 | D | |||||||||||||||
7/13/26 16:27 | 7/9/26 | NBIX | Health | BioPrd | Biological Products, (No Diag | Lippoldt Darin | CA | O | GC | 2 | S.dm | -3,498 | 174.88 | 0 | -20 | 55 | D | |||||||||||||||
6/9/26 17:40 | 6/5/26 | NBIX | Health | BioPrd | Biological Products, (No Diag | Sherwin Stephen A | CA | D | 1 | S.d | -4,133 | 165.32 | 0 | -25 | 16 | D | ||||||||||||||||
6/4/26 18:02 | 6/2/26 | NBIX | Health | BioPrd | Biological Products, (No Diag | Cooke Julie | CA | O | CHRO | 1 | S.d | -5,770 | 156.22 | 0 | -37 | 22 | D | |||||||||||||||
6/2/26 18:08 | 6/1/26 | NBIX | Health | BioPrd | Biological Products, (No Diag | Onyia Jude | CA | O | Chief Sc | 2 | S.d | -3,474 | 157.89 | 0 | -22 | 26 | D | |||||||||||||||
5/28/26 18:08 | 5/26/26 | NBIX | Health | BioPrd | Biological Products, (No Diag | Boyer David W. | CA | O | Chief Co | 1 | S | -609 | 156.64 | 0 | -4 | 8 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |